Global

‡ In these countries please contact our distributor

Smith & Nephew ottiene in Italia il riconoscimento di Great Place to Work

Italy Great Place to Work Logo

Smith & Nephew (LSE: SN, NYSE: SNN), azienda globale di tecnologie mediche, è lieta di annunciare che ha raggiunto l’importante obiettivo di essere accreditata tra le “Migliori Aziende in cui lavorare” dall’istituto italiano del Great Place to Work.

Questo è un grande privilegio per Smith & Nephew Italia ed è il risultato della combinazione dell’elevato impegno profuso dal management, l’entusiasmo dei propri dipendenti e gli sforzi fatti complessivamente per attirare, sviluppare e trattenere persone di talento.

Per ottenere l’autorevole qualifica di Great Place to Work i dipendenti hanno completato un questionario che misura il loro indice di fiducia verso l’azienda (Trust Index) e il management ha partecipato ad un Culture Audit. Entrambi questi strumenti valutano le prestazioni aziendali rispetto a cinque dimensioni chiave: credibilità, rispetto, equità, orgoglio e cameratismo.

Diogo Moreira-Rato, Presidente Smith & Nephew Europa e Canada ha commentato:

“Per Smith & Nephew, essere un Great Place to Work significa avere dipendenti orgogliosi ed entusiasti di recarsi quotidianamente sul proprio posto di lavoro, perché sono consapevoli di svolgere un’attività che fa la differenza per i clienti e per i pazienti. E’ un ambiente di lavoro dove ottengono i giusti riconoscimenti per le prestazioni e i risultati conseguiti e che, soprattutto, merita la loro fiducia.”

- ends -

 

Per domande

Media

Cristina Di Maria
Smith & Nephew
+39 039 60941

Sue Myers
Smith & Nephew
+44 (0) 1482 673229

 

 

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 90 countries. Annual sales in 2013 were more than $4.3 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN). 

For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com, follow @SmithNephew plc on Twitter or visit SmithNephew plc on Facebook.com

 

Forward-Looking Statements

This document may contain forward-looking statements that may or may not prove accurate.  For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements.  Phrases such as "aim", "plan","intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements.  Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions and our success in integrating acquired businesses; and numerous other matters that affect us or our markets, including those of a political, economic, business or competitive nature.  Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors.

Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution.  Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

◊ Trademark of Smith & Nephew. Registered US Patent and Trademark Office.